Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $484.40M.
ENTERPRISE VALUE (EV)
$484.40M
NeuroPace, Inc.
Market Cap
$445.09M
Enterprise Value (EV)
$484.40M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| NeuroPace, Inc. (NPCE) | $445.09M | $484.40M |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $444.98M | $440.04M |
| Ovid Therapeutics Inc. (OVID)vs › | $444.69M | $446.08M |
| Capricor Therapeutics, Inc. (CAPR)vs › | $441.97M | $512.08M |
| NRC Health (NRC)vs › | $457.04M | $543.75M |
| Assembly Biosciences, Inc. (ASMB)vs › | $435.38M | $405.45M |
| Tectonic Therapeutic, Inc. (TECX)vs › | $432.39M | $209.72M |
| Editas Medicine, Inc. (EDIT)vs › | $430.17M | $263.87M |
| NeoGenomics, Inc. (NEO)vs › | $428.59M | $731.42M |
| Sight Sciences, Inc. (SGHT)vs › | $465.75M | $427.97M |
Market Cap
$445.09M
Total Debt
$61.00M
Cash
$21.69M
Enterprise Value
$484.40M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
